Literature DB >> 12403655

Systemic drug therapy for restenosis: "déjà vu all over again".

David P Faxon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403655     DOI: 10.1161/01.cir.0000038412.38399.d5

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Multi-vessel coronary disease and percutaneous coronary intervention.

Authors:  C Casey; David P Faxon
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 2.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

3.  Application of quality by design (QbD) approach to ultrasonic atomization spray coating of drug-eluting stents.

Authors:  Martin McDermott; Sharmista Chatterjee; Xiaoli Hu; Ariel Ash-Shakoor; Reginald Avery; Anastasiya Belyaeva; Celia Cruz; Minerva Hughes; Joanne Leadbetter; Conrad Merkle; Taylor Moot; Sepideh Parvinian; Dinesh Patwardhan; David Saylor; Nancy Tang; Tina Zhang
Journal:  AAPS PharmSciTech       Date:  2015-01-07       Impact factor: 3.246

Review 4.  Angiotensin antagonism in coronary artery disease: results after coronary revascularisation.

Authors:  Flavio Ribichini; Valeria Ferrero; Andrea Rognoni; Giovanni Vacca; Corrado Vassanelli
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.

Authors:  Pramod Kuchulakanti; Ron Waksman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.

Authors:  Gil Aizik; Etty Grad; Gershon Golomb
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

Review 7.  Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential.

Authors:  Valeria Ferrero; Flavio Ribichini; Gabriele Pesarini; Sandra Brunelleschi; Corrado Vassanelli
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Efficacy of intramuscular methyl prednisolone in preventing restenosis after coronary artery stenting with bare-metal stainless steel stent: a double-blind, randomised, controlled clinical trial.

Authors:  M Namdari; M Ghafarzadeh; M A Nikoo
Journal:  Cardiovasc J Afr       Date:  2011 Mar-Apr       Impact factor: 1.167

9.  Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.

Authors:  Young Joon Hong; Myung Ho Jeong; Sang Rok Lee; Seo Na Hong; Kye Hun Kim; Hyung Wook Park; Ju Han Kim; Weon Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

10.  Predicting in vivo efficacy of potential restenosis therapies by cell culture studies: species-dependent susceptibility of vascular smooth muscle cells.

Authors:  Hila Epstein; Laura Rabinovich; Shmuel Banai; Vicktoria Elazar; Jianchuan Gao; Michael Chorny; Haim D Danenebrg; Gershon Golomb
Journal:  Open Cardiovasc Med J       Date:  2008-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.